SCHEMBL70211

SCHEMBL70211

CCCCN1/C(=C\C=C\C2=[N+](CCCC)c3ccccc3C2(C)C)C(C)(C)c2ccccc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 9/20 0.76
MAPT P10636 4/20 0.64
NPC1 O15118 3/20 0.64
RAB9A P51151 3/20 0.64
BLM P54132 3/20 0.64
MEN1 O00255 3/20 0.64
HTT P42858 3/20 0.64
KMT2A Q03164 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
USP2 O75604 2/20 0.64
LMNA P02545 2/20 0.64
POLB P06746 2/20 0.64
THRB P10828 2/20 0.64
PKM P14618 2/20 0.64
XBP1 P17861 2/20 0.64
RECQL P46063 2/20 0.64
NPSR1 Q6W5P4 2/20 0.64
S1PR2 O95136 1/20 0.64
ALPG P10696 1/20 0.64
CRHBP P24387 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12364478 1.00 PRMT1 (0.76) PRMT1MAPTNPC1RAB9ABLM
SCHEMBL70106 1.00 PRMT1 (0.76) PRMT1MAPTNPC1RAB9ABLM
SCHEMBL11964723 1.00 PRMT1 (0.76) PRMT1MAPTNPC1RAB9ABLM
Iodide SCHEMBL15347919 0.99 PRMT1 (0.75) PRMT1MAPTNPC1RAB9ABLM
Iodide SCHEMBL872878 0.99 PRMT1 (0.75) PRMT1MAPTNPC1RAB9ABLM
SCHEMBL10001890 0.96 PRMT1 (0.70) PRMT1MAPTNPC1RAB9ABLM
SCHEMBL3854893 0.96 PRMT1 (0.70) PRMT1MAPTNPC1RAB9ABLM
SCHEMBL10066294 0.96 PRMT1 (0.70) PRMT1MAPTNPC1RAB9ABLM
SCHEMBL30375050 0.96 PRMT1 (0.70) PRMT1MAPTNPC1RAB9ABLM
SCHEMBL70234 0.96 PRMT1 (0.70) PRMT1MAPTNPC1RAB9ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906490-B2 Multicolor mask EASTMAN KODAK COMPANY (US) 2014-12-09 US disclosed
US-8906490-B2 Multicolor mask EASTMAN KODAK COMPANY (US) 2014-12-09 US disclosed
US-8715894-B2 Integrated color mask EASTMAN KODAK COMPANY (US) 2014-05-06 US disclosed
US-8715894-B2 Integrated color mask EASTMAN KODAK COMPANY (US) 2014-05-06 US disclosed
US-8664673-B2 Multicolored mask process for making display circuitry EASTMAN KODAK COMPANY (US) 2014-03-04 US disclosed
US-8664673-B2 Multicolored mask process for making display circuitry EASTMAN KODAK COMPANY (US) 2014-03-04 US disclosed
US-20130287700-A1 COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM KLINIKUM DARMSTADT GMBH (DE) 2013-10-31 US disclosed
US-20130287700-A1 COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM KLINIKUM DARMSTADT GMBH (DE) 2013-10-31 US disclosed
US-20120231239-A1 INTEGRATED COLOR MASK BANK OF AMERICA, N.A., AS AGENT 2012-09-13 US disclosed
US-20120231239-A1 INTEGRATED COLOR MASK BANK OF AMERICA, N.A., AS AGENT 2012-09-13 US disclosed
US-20090130610-A1 Integrated color mask EASTMAN KODAK COMPANY 2009-05-21 US disclosed
US-20090130610-A1 Integrated color mask EASTMAN KODAK COMPANY 2009-05-21 US disclosed
US-20090130609-A1 Colored mask combined with selective area deposition NPEC INC. 2009-05-21 US disclosed
US-20090130609-A1 Colored mask combined with selective area deposition NPEC INC. 2009-05-21 US disclosed
US-20090130600-A1 Multicolored mask process for making display circuitry QUALEX INC. 2009-05-21 US disclosed
US-20090130398-A1 Gradient colored mask LASER PACIFIC MEDIA CORPORATION 2009-05-21 US disclosed
US-20090130600-A1 Multicolored mask process for making display circuitry QUALEX INC. 2009-05-21 US disclosed
US-20090130397-A1 Multicolor mask BANK OF AMERICA, N.A., AS AGENT 2009-05-21 US disclosed
US-20070269750-A1 Colored masking for forming transparent structures EASTMAN KODAK COMPANY 2007-11-22 US disclosed
US-20070269750-A1 Colored masking for forming transparent structures EASTMAN KODAK COMPANY 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130287700-A1 COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM SNCA, MAPT, TARDBP PRMT1 4003/4885MAPT 2/4885NPC1 1633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.